These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28840637)

  • 21. Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine.
    Tomiyama H; Kimura Y; Kuwabara Y; Maruyama C; Yoshida Y; Kuwata S; Kinouchi T; Yoshida H; Doba N
    Hypertens Res; 2001 Nov; 24(6):679-84. PubMed ID: 11768727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
    Fogari R; Derosa G; Zoppi A; Preti P; Lazzari P; Destro M; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2007 Apr; 20(4):417-22. PubMed ID: 17386350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P;
    Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
    Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
    Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
    Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.
    Fujita T; Ando K; Nishimura H; Ideura T; Yasuda G; Isshiki M; Takahashi K;
    Kidney Int; 2007 Dec; 72(12):1543-9. PubMed ID: 17943080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
    Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
    Hypertens Res; 2011 Aug; 34(8):935-41. PubMed ID: 21654755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The L/N-type calcium channel blocker, Cilnidipine, reduces heart rate and albuminuria in patients with type 2 diabetes.
    Tanaka M
    J Int Med Res; 2010; 38(2):602-10. PubMed ID: 20515573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
    Shimizu H; Nakagami H; Yasumasa N; Mariana OK; Kyutoku M; Koriyama H; Nakagami F; Shimamura M; Rakugi H; Morishita R
    Hypertens Res; 2012 Jan; 35(1):77-81. PubMed ID: 21881574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
    Ogawa H; Kim-Mitsuyama S; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K;
    Am J Med; 2012 Oct; 125(10):981-90. PubMed ID: 22503610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T; Ueno M; Tominaga M; Kajioka T; Onaka U; Eto K; Goto K
    Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?
    Ay SA; Cakar M; Karaman M; Balta S; Demirkol S; Unlu M; Kurt O; Altun B; Akhan M; Arslan E; Koc B; Bulucu F
    Ren Fail; 2013; 35(3):357-60. PubMed ID: 23297711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the L/N-Type Ca
    Harada E; Sugino K; Aimoto M; Takahara A
    Biol Pharm Bull; 2021 May; 44(5):707-713. PubMed ID: 33642455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
    Nozato S; Yamamoto K; Nozato Y; Takeda M; Hongyo K; Takeya M; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Ito N; Rakugi H
    Hypertens Res; 2018 Apr; 41(4):290-298. PubMed ID: 29449705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
    Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.
    Fogari R; Preti P; Zoppi A; Rinaldi A; Corradi L; Pasotti C; Poletti L; Marasi G; Derosa G; Mugellini A; Voglini C; Lazzari P
    Am J Hypertens; 2002 Dec; 15(12):1042-9. PubMed ID: 12460699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markov modeling analysis of health and economic outcomes of therapy with valsartan versus amlodipine in patients with type 2 diabetes and microalbuminuria.
    Smith DG; Nguyen AB; Peak CN; Frech FH
    J Manag Care Pharm; 2004; 10(1):26-32. PubMed ID: 14720103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Randomized Open-Label Parallel-Group Study Comparing the Efficacy and Safety of Cilnidipine and Amlodipine in Hypertensive Adults.
    Jj NK; D DC; Kavitha R
    J Assoc Physicians India; 2022 Dec; 69(12):11-12. PubMed ID: 35057591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.